News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 18, 2022, 07:55 ET Oramed to Present at H.C. Wainwright Global Investment Conference

Oramed Pharmaceuticals Inc. (Nasdaq:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

May 03, 2022, 08:10 ET Oramed schließt Patientenrekrutierung für die pivotale Phase-3-Studie mit oralem Insulin ORA-D-013-1 ab

May 03, 2022, 08:10 ET Oramed finaliza la inscripción de pacientes en el estudio ORA-D-013-1

May 03, 2022, 08:10 ET Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery...

May 03, 2022, 08:10 ET Oramed termine le recrutement des patients dans l'étude pivot de phase 3 sur l'insuline orale ORA-D-013-1

May 03, 2022, 08:10 ET Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1

Apr 05, 2022, 08:25 ET Oramed Granted NASH Patent in Europe

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms,...

Apr 04, 2022, 08:25 ET Oramed Appoints Yadin Rozov to its Board of Directors

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms,...

Mar 29, 2022, 08:25 ET Oramed's Diabetes Market Survey Shows Strong Interest for ORMD-0801 Oral Insulin Candidate Among Physicians

NEW YORK, March 29, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical...

Mar 22, 2022, 08:25 ET Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Mar 16, 2022, 08:25 ET Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery...

Mar 10, 2022, 08:25 ET Oramed to Present at Barclays Global Healthcare Conference

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Jan 12, 2022, 08:45 ET Oramed Issues Annual Message to Shareholders

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery...

Jan 05, 2022, 07:30 ET Oramed Granted Key European Patent for Platform Technology in Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Dec 29, 2021, 06:47 ET Oravax Medical, filiale d'Oramed, signe un accord de coopération et d'achat pour un préachat initial de 10 millions de doses de vaccins oraux COVID-19 avec Tan Thanh Holdings en vue d'une commercialisation en Asie du Sud-Est

Dec 29, 2021, 06:00 ET Oramed-Tochtergesellschaft Oravax Medical unterzeichnet Kooperations- und Kaufvertrag für einen ersten Vorabkauf von 10 Millionen Dosen oraler COVID-19-Impfstoffe mit Tan Thanh Holdings zur Vermarktung in Südostasien

Dec 29, 2021, 06:00 ET Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Dec 29, 2021, 06:00 ET Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

Dec 29, 2021, 06:00 ET Oravax Medical acuerda la compra anticipada inicial de 10 millones de vacunas orales contra la COVID-19

Dec 14, 2021, 09:35 ET Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Dec 08, 2021, 07:30 ET Oramed Pharmaceuticals Appoints Chief Legal Officer

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Nov 24, 2021, 08:40 ET Oramed to Join MSCI USA Small Cap Index

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Nov 23, 2021, 08:25 ET Oramed Reaches 75% Enrollment in Phase 3 Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Nov 11, 2021, 09:25 ET Oramed to Present at H.C. Wainwright 7th Annual Israel Conference

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Nov 08, 2021, 08:10 ET Oramed Announces Closing of $50 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Oramed Pharmaceuticals Inc. ("Oramed" or the "Company") (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused ...